{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:08:18Z","timestamp":1778713698871,"version":"3.51.4"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007922","name":"Spinal Research","doi-asserted-by":"publisher","award":["NRB117"],"award-info":[{"award-number":["NRB117"]}],"id":[{"id":"10.13039\/501100007922","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013790","name":"Brain Research UK","doi-asserted-by":"publisher","award":["201617"],"award-info":[{"award-number":["201617"]}],"id":[{"id":"10.13039\/100013790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR \/V002783\/1"],"award-info":[{"award-number":["MR \/V002783\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/S011110\/1"],"award-info":[{"award-number":["MR\/S011110\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/S026053\/1"],"award-info":[{"award-number":["MR\/S026053\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.expneurol.2021.113945","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T10:44:34Z","timestamp":1638960274000},"page":"113945","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Peripherally delivered Adeno-associated viral vectors for spinal cord injury repair"],"prefix":"10.1016","volume":"348","author":[{"given":"Jared D.","family":"Sydney-Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline B.","family":"Spejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippa M.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence D.F.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2021.113945_bb0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ana.10099","article-title":"Is the therapeutic application of neurotrophic factors dead?","volume":"51","author":"Apfel","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2021.113945_bb0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/5669","article-title":"Neurotrophin-3 is required for proper cerebellar development","volume":"2","author":"Bates","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2021.113945_bb0015","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41598-020-57893-z","article-title":"Capsid-specific removal of circulating antibodies to adeno-associated virus vectors","volume":"10","author":"Bertin","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2021.113945_bb0020","series-title":"Big Pharma Buys Further into Gene Therapy","author":"Bhambra","year":"2020"},{"key":"10.1016\/j.expneurol.2021.113945_bb0025","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0306-4522(02)00970-3","article-title":"Adeno-associated viral vector-mediated neurotrophin gene transfer in the injured adult rat spinal cord improves hind-limb function","volume":"118","author":"Blits","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2021.113945_bb0030","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2174\/1566523215666150630121750","article-title":"The skeletal muscle environment and its role in immunity and tolerance to AAV vector-mediated gene transfer","volume":"15","author":"Boisgerault","year":"2015","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.expneurol.2021.113945_bb0035","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/978-3-642-45106-5_16","article-title":"Neurotrophic factors in spinal cord injury","volume":"220","author":"Boyce","year":"2014","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.expneurol.2021.113945_bb0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fncir.2014.00059","article-title":"Neurotrophins and spinal circuit function","volume":"8","author":"Boyce","year":"2014","journal-title":"Front Neural Circuits"},{"key":"10.1016\/j.expneurol.2021.113945_bb0045","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1460-9568.2011.07950.x","article-title":"Differential effects of brain-derived neurotrophic factor and neurotrophin-3 on hindlimb function in paraplegic rats","volume":"35","author":"Boyce","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2021.113945_bb0050","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1046\/j.1460-9568.1999.00809.x","article-title":"NT-3 promotes growth of lesioned adult rat sensory axons ascending in the dorsal columns of the spinal cord","volume":"11","author":"Bradbury","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2021.113945_bb0055","doi-asserted-by":"crossref","first-page":"9728","DOI":"10.1523\/JNEUROSCI.1924-10.2010","article-title":"Local and remote growth factor effects after primate spinal cord injury","volume":"30","author":"Brock","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2021.113945_bb0060","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s41467-021-20980-4","article-title":"Improving hindlimb locomotor function by non-invasive AAV-mediated manipulations of propriospinal neurons in mice with complete spinal cord injury","volume":"12","author":"Brommer","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2021.113945_bb0065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/humc.2013.087","article-title":"Lessons learned from the clinical development and market authorization of Glybera","volume":"24","author":"Bryant","year":"2013","journal-title":"Hum Gene Ther Clin Dev"},{"key":"10.1016\/j.expneurol.2021.113945_bb0070","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s41587-020-00793-4","article-title":"Deep diversification of an AAV capsid protein by machine learning","volume":"39","author":"Bryant","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.expneurol.2021.113945_bb0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.expneurol.2021.113945_bb0080","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1093\/brain\/awy158","article-title":"Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury","volume":"141","author":"Burnside","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2021.113945_bb0085","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1152\/physrev.00007.2008","article-title":"Cardiovascular actions of neurotrophins","volume":"89","author":"Caporali","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.expneurol.2021.113945_bb0090","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/nn.4593","article-title":"Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems","volume":"20","author":"Chan","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2021.113945_bb0095","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1155\/2019\/3017678","article-title":"Intramuscular injection of Adenoassociated virus encoding human Neurotrophic factor 3 and exercise intervention contribute to reduce spasms after spinal cord injury","volume":"2019","author":"Chang","year":"2019","journal-title":"Neural Plasticity"},{"key":"10.1016\/j.expneurol.2021.113945_bb0100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/(SICI)1097-4598(200002)23:2<189::AID-MUS7>3.0.CO;2-8","article-title":"Tolerability of recombinant-methionyl human neurotrophin-3 (r-metHuNT3) in healthy subjects","volume":"23","author":"Chaudhry","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2021.113945_bb0105","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/jnr.23257","article-title":"Neuroimmune processes associated with Wallerian degeneration support neurotrophin-3-induced axonal sprouting in the injured spinal cord","volume":"91","author":"Chen","year":"2013","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2021.113945_bb0110","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1089\/neu.2006.23.1254","article-title":"Expression of neurotrophin-3 promotes axonal plasticity in the acute but not chronic injured spinal cord","volume":"23","author":"Chen","year":"2006","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.expneurol.2021.113945_bb0115","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.expneurol.2007.11.025","article-title":"Immune activation is required for NT-3-induced axonal plasticity in chronic spinal cord injury","volume":"209","author":"Chen","year":"2008","journal-title":"Exp. Neurol."},{"issue":"521\u2013535","key":"10.1016\/j.expneurol.2021.113945_bb0120","article-title":"Reactivation of dormant relay pathways in injured spinal cord by KCC2 manipulations","volume":"174","author":"Chen","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2021.113945_bb0125","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.omtm.2019.11.006","article-title":"rAAV2-retro enables extensive and High-efficient transduction of lower motor neurons following intramuscular injection","volume":"17","author":"Chen","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.expneurol.2021.113945_bb0130","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1182\/blood-2003-11-3845","article-title":"Autoimmune anemia in macaques following erythropoietin gene therapy","volume":"103","author":"Chenuaud","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.expneurol.2021.113945_bb0135","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ymthe.2003.12.015","article-title":"Optimal design of a single recombinant adeno-associated virus derived from serotypes 1 and 2 to achieve more tightly regulated transgene expression from nonhuman primate muscle","volume":"9","author":"Chenuaud","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2021.113945_bb0140","first-page":"11","article-title":"Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: results of a phase 1 trial","author":"Chiocca","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.expneurol.2021.113945_bb0145","doi-asserted-by":"crossref","first-page":"16027","DOI":"10.1038\/mtm.2016.27","article-title":"A regulatable AAV vector mediating GDNF biological effects at clinically-approved sub-antimicrobial doxycycline doses","volume":"5","author":"Chtarto","year":"2016","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.expneurol.2021.113945_bb0150","author":"Clarkson"},{"key":"10.1016\/j.expneurol.2021.113945_bb0155","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/0306-4522(94)90578-9","article-title":"Selective expression of neurotrophin-3 messenger RNA in muscle spindles of the rat","volume":"63","author":"Copray","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2021.113945_bb0160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/gast.2000.8553","article-title":"Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans","volume":"119","author":"Coulie","year":"2000","journal-title":"Gastroenterol"},{"key":"10.1016\/j.expneurol.2021.113945_bb0165","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nm0197-73","article-title":"Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys","volume":"3","author":"Crowe","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2021.113945_bb0170","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/mcne.1998.0704","article-title":"Neuronal injury increases retrograde axonal transport of the neurotrophins to spinal sensory neurons and motor neurons via multiple receptor mechanisms","volume":"12","author":"Curtis","year":"1998","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2021.113945_bb0175","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2174\/1566523216666160524144041","article-title":"Tet-on systems for doxycycline-inducible gene expression","volume":"16","author":"Das","year":"2016","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.expneurol.2021.113945_bb0180","doi-asserted-by":"crossref","first-page":"27053","DOI":"10.1073\/pnas.1910061116","article-title":"A systematic capsid evolution approach performed in vivo for the design of AAV vectors with tailored properties and tropism","volume":"116","author":"Davidsson","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.expneurol.2021.113945_bb0185","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41434-018-0028-5","article-title":"More expansive gene transfer to the rat CNS: AAV PHP.EB vector dose\u2013response and comparison to AAV PHP.B","volume":"25","author":"Dayton","year":"2018","journal-title":"Gene Ther."},{"key":"10.1016\/j.expneurol.2021.113945_bb0190","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nbt.3440","article-title":"Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain","volume":"34","author":"Deverman","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.expneurol.2021.113945_bb0195","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/0896-6273(92)90213-W","article-title":"The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons","volume":"8","author":"DiStefano","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2021.113945_bb0200","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/brain\/awv341","article-title":"Delayed intramuscular human neurotrophin-3 improves recovery in adult and elderly rats after stroke","volume":"139","author":"Duricki","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2021.113945_bb0205","article-title":"Subcutaneous neurotrophin-3 infusion induces corticospinal neuroplasticity and improvements in dexterity and walking in elderly rats after large cortical stroke","author":"Duricki","year":"2018","journal-title":"BioRxiv."},{"key":"10.1016\/j.expneurol.2021.113945_bb0210","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.25386","article-title":"Stroke recovery in rats after 24-hour-delayed intramuscular Neurotrophin-3 infusion","volume":"85","author":"Duricki","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2021.113945_bb0215","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s41587-020-0569-1","article-title":"Dyno advances AI-powered gene therapy","volume":"38","author":"Editorial","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.expneurol.2021.113945_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113037","article-title":"Enhanced regeneration and reinnervation following timed GDNF gene therapy in a cervical ventral root avulsion","volume":"321","author":"Eggers","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2021.113945_bb0225","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/brain\/awy340","article-title":"Timed GDNF gene therapy using an immune-evasive gene switch promotes long distance axon regeneration","volume":"142","author":"Eggers","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2021.113945_bb0230","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1039\/C4BM00311J","article-title":"Sustained delivery of bioactive neurotrophin-3 to the injured spinal cord","volume":"3","author":"Elliott Donaghue","year":"2015","journal-title":"Biomater Sci"},{"key":"10.1016\/j.expneurol.2021.113945_bb0235","doi-asserted-by":"crossref","first-page":"11605","DOI":"10.1128\/JVI.76.22.11605-11611.2002","article-title":"Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus","volume":"76","author":"Favre","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.expneurol.2021.113945_bb0240","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1089\/neu.2008.0807","article-title":"Muscle injection of AAV-NT3 promotes anatomical reorganization of CST axons and improves behavioral outcome following SCI","volume":"26","author":"Fortun","year":"2009","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.expneurol.2021.113945_bb0245","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.expneurol.2021.113945_bb0250","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ana.22009","article-title":"Nogo-a antibodies and training reduce muscle spasms in spinal cord-injured rats","volume":"68","author":"Gonzenbach","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2021.113945_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113725","article-title":"Liver inflammation at the time of spinal cord injury enhances intraspinal pathology, liver injury, metabolic syndrome and locomotor deficits","volume":"342","author":"Goodus","year":"2021","journal-title":"Exp. Neurol."},{"issue":"1449\u20131464","key":"10.1016\/j.expneurol.2021.113945_bb0260","article-title":"Enhancer viruses for combinatorial cell-subclass-specific labeling","volume":"109","author":"Graybuck","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2021.113945_bb0265","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jnr.490420104","article-title":"Expression of neurotrophins in skeletal muscle: quantitative comparison and significance for motoneuron survival and maintenance of function","volume":"42","author":"Griesbeck","year":"1995","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2021.113945_bb0270","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1128\/JVI.00254-08","article-title":"In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of Adeno-associated viruses","volume":"82","author":"Grimm","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.expneurol.2021.113945_bb0275","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1038\/s41467-019-13854-3","article-title":"Descending motor circuitry required for NT-3 mediated locomotor recovery after spinal cord injury in mice","volume":"10","author":"Han","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2021.113945_bb0280","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/hum.2018.015","article-title":"Severe toxicity in nonhuman Primates and piglets following High-dose intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN","volume":"29","author":"Hinderer","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2021.113945_bb0285","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ymthe.2018.01.018","article-title":"The neurotropic properties of AAV-PHP.B are limited to C57BL\/6J mice","volume":"26","author":"Hordeaux","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2021.113945_bb0290","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba9188","article-title":"MicroRNA-mediated inhibition of transgene expression reduces dorsal root ganglion toxicity by AAV vectors in primates","volume":"12","author":"Hordeaux","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.expneurol.2021.113945_bb0295","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/gt.2014.22","article-title":"Developing a potentially immunologically inert tetracycline-regulatable viral vector for gene therapy in the peripheral nerve","volume":"21","author":"Hoyng","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.expneurol.2021.113945_bb0300","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1126\/science.1258996","article-title":"Neurodevelopment. Dendrite morphogenesis depends on relative levels of NT-3\/TrkC signaling","volume":"346","author":"Joo","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2021.113945_bb0305","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.4103\/1673-5374.257518","article-title":"Delayed peripheral treatment with neurotrophin-3 improves sensorimotor recovery after central nervous system injury","volume":"14","author":"Kakanos","year":"2019","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.expneurol.2021.113945_bb0310","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1086137","article-title":"Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model","volume":"301","author":"Kaspar","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2021.113945_bb0315","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18146","article-title":"Intramuscular Neurotrophin-3 normalizes low threshold spinal reflexes, reduces spasms and improves mobility after bilateral corticospinal tract injury in rats","volume":"5","author":"Kathe","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.expneurol.2021.113945_bb0320","first-page":"e18146","article-title":"Intramuscular Neurotrophin-3 normalizes low threshold spinal reflexes, reduces spasms and improves mobility after bilateral corticospinal tract injury in rats","volume":"eLife 5","author":"Kathe","year":"2016"},{"key":"10.1016\/j.expneurol.2021.113945_bb0325","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0306-4522(99)00072-X","article-title":"trkA, trkB, and trkC messenger RNA expression by bulbospinal cells of the rat","volume":"92","author":"King","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2021.113945_bb0330","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/mt.2016.62","article-title":"Pulmonary targeting of Adeno-associated viral vectors by next-generation sequencing-guided screening of random capsid displayed peptide libraries","volume":"24","author":"K\u00f6rbelin","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2021.113945_bb0335","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1089\/neu.2016.4559","article-title":"Transplants of Neurotrophin-producing autologous fibroblasts promote recovery of treadmill stepping in the acute, sub-chronic, and chronic spinal cat","volume":"34","author":"Krupka","year":"2017","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.expneurol.2021.113945_bb0340","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/d41573-021-00017-7","article-title":"The clinical landscape for AAV gene therapies","volume":"20","author":"Kuzmin","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.expneurol.2021.113945_bb0345","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.omtm.2019.05.002","article-title":"In-depth characterization of a mifepristone-regulated expression system for AAV5-mediated gene therapy in the liver","volume":"13","author":"Liefhebber","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.expneurol.2021.113945_bb0350","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.35","article-title":"Adeno-associated virus-mediated, mifepristone-regulated transgene expression in the brain","volume":"2","author":"Maddalena","year":"2013","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.expneurol.2021.113945_bb0355","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.omtm.2020.10.011","article-title":"CNS transduction benefits of AAV-PHP.eB over AAV9 are dependent on administration route and mouse strain","volume":"19","author":"Mathiesen","year":"2020","journal-title":"Mol. Ther. Meth. Clin. Develop."},{"key":"10.1016\/j.expneurol.2021.113945_bb0360","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neulet.2017.11.049","article-title":"Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain","volume":"665","author":"Matsuzaki","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2021.113945_bb0365","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ana.22251","article-title":"Sustained alpha-sarcoglycan gene expression after gene transfer in limb-girdle muscular dystrophy, type 2D","volume":"68","author":"Mendell","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2021.113945_bb0370","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ymthe.2020.12.007","article-title":"Current clinical applications of in vivo gene therapy with AAVs","volume":"29","author":"Mendell","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2021.113945_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108754","article-title":"Functional enhancer elements drive subclass-selective expression from mouse to primate neocortex","volume":"34","author":"Mich","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.expneurol.2021.113945_bb0380","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to AAV vectors: overcoming barriers to successful gene therapy","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.expneurol.2021.113945_bb0385","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0009-8981(94)90132-5","article-title":"Neurotrophin-3 (NT-3) levels in the developing rat nervous system and in human samples","volume":"227","author":"Murase","year":"1994","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.expneurol.2021.113945_bb0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2018.05.007","article-title":"The spleen as a neuroimmune interface after spinal cord injury","volume":"321","author":"Noble","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2021.113945_bb0395","unstructured":"Nonnenmacher, M., Li, S., Wang, W., Child, M.A., Ren, A.Z., Tyson, K., Pande, N., Lu, X., Li, J., Ren, X.-Q., 2021a. RNA-driven evolution of AAV capsid libraries identifies variants with High transduction efficiency in non-human primate central nervous system, MOLECULAR THERAPY. CELL PRESS 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA, pp. 25-26."},{"key":"10.1016\/j.expneurol.2021.113945_bb0400","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.omtm.2020.12.006","article-title":"Rapid evolution of blood-brain-barrier-penetrating AAV capsids by RNA-driven biopanning","volume":"20","author":"Nonnenmacher","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.expneurol.2021.113945_bb0405","series-title":"New Zolgensma data demonstrate age-appropriate development when used early, real-world benefit in older children and durability 5+ years post-treatment","author":"Novartis","year":"2021"},{"key":"10.1016\/j.expneurol.2021.113945_bb0410","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.618020","article-title":"AAV targeting of glial cell types in the central and peripheral nervous system and relevance to human gene therapy","volume":"13","author":"O\u2019Carroll","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.expneurol.2021.113945_bb0415","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/1545968314532834","article-title":"Either brain-derived neurotrophic factor or neurotrophin-3 only neurotrophin-producing grafts promote locomotor recovery in untrained spinalized cats","volume":"29","author":"Ollivier-Lanvin","year":"2015","journal-title":"Neurorehabil. Neural Repair"},{"key":"10.1016\/j.expneurol.2021.113945_bb0420","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/sj.mt.6300246","article-title":"Long-term skeletal muscle protection after gene transfer in a mouse model of LGMD-2D","volume":"15","author":"Pacak","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2021.113945_bb0425","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.gt.3302895","article-title":"Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo","volume":"14","author":"Palomeque","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.expneurol.2021.113945_bb0430","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0169-409X(98)00086-6","article-title":"Penetration of neurotrophins and cytokines across the blood-brain\/blood-spinal cord barrier","volume":"36","author":"Pan","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.expneurol.2021.113945_bb0435","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0006-8993(97)01525-4","article-title":"Permeability of the blood-brain barrier to neurotrophins","volume":"788","author":"Pan","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2021.113945_bb0440","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/j.1572-0241.2003.t01-1-07477.x","article-title":"Neurotrophin-3 improves functional constipation","volume":"98","author":"Parkman","year":"2003","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.expneurol.2021.113945_bb0445","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1152\/jn.00480.2015","article-title":"Spinal electro-magnetic stimulation combined with transgene delivery of neurotrophin NT-3 and exercise: novel combination therapy for spinal contusion injury","volume":"114","author":"Petrosyan","year":"2015","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.expneurol.2021.113945_bb0450","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1460-9568.2010.07392.x","article-title":"Intramuscular AAV delivery of NT-3 alters synaptic transmission to motoneurons in adult rats","volume":"32","author":"Petruska","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2021.113945_bb0455","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1089\/hum.2020.29123.bfs","article-title":"Merck KGaA doubles down on viral, gene therapy manufacturing","author":"Philippidis","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2021.113945_bb0460","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1089\/hum.2020.29146.bfs","article-title":"Eli Lilly establishes gene therapy program with $1B purchase of prevail","volume":"10","author":"Philippidis","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2021.113945_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.135956","article-title":"Comparative study of neuron-specific promoters in mouse brain transduced by intravenously administered AAV-PHP.eB","volume":"756","author":"Radhiyanti","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2021.113945_bb0470","doi-asserted-by":"crossref","first-page":"E5595","DOI":"10.1073\/pnas.1804735115","article-title":"NT3-chitosan enables de novo regeneration and functional recovery in monkeys after spinal cord injury","volume":"115","author":"Rao","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.expneurol.2021.113945_bb0475","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/mt.2011.177","article-title":"Neutralizing antibodies against AAV serotypes 1, 2, 6, and 9 in sera of commonly used animal models","volume":"20","author":"Rapti","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2021.113945_bb0480","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171937","article-title":"The swimming test is effective for evaluating spasticity after contusive spinal cord injury","volume":"12","author":"Ryu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2021.113945_bb0485","doi-asserted-by":"crossref","first-page":"7120","DOI":"10.1038\/s41598-021-85961-5","article-title":"Early escitalopram administration as a preemptive treatment strategy against spasticity after contusive spinal cord injury in rats","volume":"11","author":"Ryu","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2021.113945_bb0490","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/s41591-021-01351-4","article-title":"Partial recovery of visual function in a blind patient after optogenetic therapy","volume":"11","author":"Sahel","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2021.113945_bb0495","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1212\/01.WNL.0000171978.70849.c5","article-title":"NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients","volume":"65","author":"Sahenk","year":"2005","journal-title":"Neurol"},{"key":"10.1016\/j.expneurol.2021.113945_bb0500","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/mt.2013.250","article-title":"AAV1.NT-3 gene therapy for Charcot-Marie-tooth neuropathy","volume":"22","author":"Sahenk","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2021.113945_bb0505","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41467-018-08283-7","article-title":"Next-generation muscle-directed gene therapy by in silico vector design","volume":"10","author":"Sarcar","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2021.113945_bb0510","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/neu.2014.3497","article-title":"Spinal cord injury causes chronic liver pathology in rats","volume":"32","author":"Sauerbeck","year":"2015","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.expneurol.2021.113945_bb0515","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/367170a0","article-title":"Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesions","volume":"367","author":"Schnell","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2021.113945_bb0520","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1093\/brain\/awy148","article-title":"An intriguing way to enhance rehabilitation of grasping in rats after spinal cord injury","volume":"141","author":"Spejo","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2021.113945_bb0525","article-title":"Muscle-specific Neurotrophin-3 gene therapy after stroke in adult rats: effects on neuroplasticity and functional recovery","author":"Spejo","year":"2021","journal-title":"BioRxiv."},{"key":"10.1016\/j.expneurol.2021.113945_bb0530","article-title":"An Adeno-associated viral vector encoding Neurotrophin 3 injected into affected forelimb muscles modestly improves sensorimotor function after contusive mid-cervical spinal cord injury","author":"Sydney-Smith","year":"2021","journal-title":"BioRxiv."},{"key":"10.1016\/j.expneurol.2021.113945_bb0535","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1089\/hum.2016.130","article-title":"Systemic and persistent muscle gene expression in Rhesus monkeys with a liver De-targeted Adeno-associated virus vector","volume":"28","author":"Tarantal","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2021.113945_bb0540","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.neuron.2016.09.021","article-title":"A designer AAV variant permits efficient retrograde access to projection neurons","volume":"92","author":"Tervo","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2021.113945_bb0545","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrn1955","article-title":"Therapeutic interventions after spinal cord injury","volume":"7","author":"Thuret","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2021.113945_bb0550","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1093\/brain\/awy128","article-title":"Eliciting inflammation enables successful rehabilitative training in chronic spinal cord injury","volume":"141","author":"Torres-Esp\u00edn","year":"2018","journal-title":"Brain."},{"key":"10.1016\/j.expneurol.2021.113945_bb0555","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/gt.2008.104","article-title":"Construction and analysis of compact muscle-specific promoters for AAV vectors","volume":"15","author":"Wang","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.expneurol.2021.113945_bb0560","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.omtm.2018.09.003","article-title":"Adeno-associated virus neutralizing antibodies in large animals and their impact on brain Intraparenchymal gene transfer","volume":"11","author":"Wang","year":"2018","journal-title":"Mol. Ther. Meth. Clin. Develop."},{"key":"10.1016\/j.expneurol.2021.113945_bb0565","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.39016","article-title":"Remodeling of lumbar motor circuitry remote to a thoracic spinal cord injury promotes locomotor recovery","volume":"7","author":"Wang","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.expneurol.2021.113945_bb0570","series-title":"Thesis of Christina Wayman, chapter 2: the effect of delayed AAV-NT3 delivery to affected forelimb muscles on sensory and motor function after permanent distal middle cerebral artery occlusion in young adult rats","author":"Wayman","year":"2021"},{"key":"10.1016\/j.expneurol.2021.113945_bb0575","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1038\/s41467-020-19230-w","article-title":"Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants","volume":"11","author":"Weinmann","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2021.113945_bb0580","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1093\/brain\/awx201","article-title":"Using an engineered glutamate-gated chloride channel to silence sensory neurons and treat neuropathic pain at the source","volume":"140","author":"Weir","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2021.113945_bb0585","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neuroscience.2014.04.041","article-title":"Vector-induced NT-3 expression in rats promotes collateral growth of injured corticospinal tract axons far rostral to a spinal cord injury","volume":"272","author":"Weishaupt","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2021.113945_bb0590","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1038\/s41598-020-63559-7","article-title":"Intra-striatal AAV2.Retro administration leads to extensive retrograde transport in the rhesus macaque brain: implications for disease modeling and therapeutic development","volume":"10","author":"Weiss","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2021.113945_bb0595","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/mt.2009.255","article-title":"Effect of genome size on AAV vector packaging","volume":"18","author":"Wu","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2021.113945_bb0600","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/gt.2015.67","article-title":"AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy","volume":"23","author":"Yalvac","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.expneurol.2021.113945_bb0605","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1523\/JNEUROSCI.23-04-01424.2003","article-title":"Neurotrophin-3 expressed in situ induces axonal plasticity in the adult injured spinal cord","volume":"23","author":"Zhou","year":"2003","journal-title":"J. Neurosci."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488621003538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488621003538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:15:25Z","timestamp":1778710525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488621003538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":121,"alternative-id":["S0014488621003538"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2021.113945","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripherally delivered Adeno-associated viral vectors for spinal cord injury repair","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2021.113945","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113945"}}